{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Metabolic+and+Nutritional+Complications&page=14", "query": { "condition": "Metabolic and Nutritional Complications", "page": 14 }, "page_size": 10 }, "pagination": { "page": 14, "page_size": 10, "total_count": 1570, "total_pages": 157, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Metabolic+and+Nutritional+Complications&page=15&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Metabolic+and+Nutritional+Complications&page=13&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T02:43:58.170Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01850654", "title": "Ohio Colorectal Cancer Prevention Initiative", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lynch Syndrome", "Colorectal Cancer" ], "interventions": [ { "name": "LS tumor screening", "type": "GENETIC" }, { "name": "Genetic testing", "type": "GENETIC" }, { "name": "Genetic Counseling", "type": "BEHAVIORAL" }, { "name": "Biorepository", "type": "OTHER" }, { "name": "Questionnaire", "type": "BEHAVIORAL" } ], "intervention_types": [ "GENETIC", "BEHAVIORAL", "OTHER" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3470, "start_date": "2012-12-26", "completion_date": "2018-01-02", "has_results": false, "last_update_posted_date": "2018-06-28", "last_synced_at": "2026-10-15T02:43:58.170Z", "location_count": 49, "location_summary": "Akron, Ohio • Barberton, Ohio • Batavia, Ohio + 29 more", "locations": [ { "city": "Akron", "state": "Ohio" }, { "city": "Akron", "state": "Ohio" }, { "city": "Barberton", "state": "Ohio" }, { "city": "Batavia", "state": "Ohio" }, { "city": "Canton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01850654" }, { "nct_id": "NCT03651505", "title": "X-linked Hypophosphatemia Disease Monitoring Program", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "X-linked Hypophosphatemia", "Hypophosphatemic Rickets" ], "interventions": [ { "name": "No intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Ultragenyx Pharmaceutical Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 782, "start_date": "2018-07-16", "completion_date": "2032-12", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-10-15T02:43:58.170Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Diego, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03651505" }, { "nct_id": "NCT06190158", "title": "Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Type 2 Diabetes", "Chronic Kidney Diseases" ], "interventions": [ { "name": "Oral sodium suppression test", "type": "DIAGNOSTIC_TEST" }, { "name": "Saline suppression test", "type": "DIAGNOSTIC_TEST" }, { "name": "Captopril suppression test", "type": "DIAGNOSTIC_TEST" }, { "name": "Dexamethasone suppression test", "type": "DIAGNOSTIC_TEST" }, { "name": "Cosyntropin stimulation test", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 125, "start_date": "2024-05-15", "completion_date": "2029-07-31", "has_results": false, "last_update_posted_date": "2026-08-13", "last_synced_at": "2026-10-15T02:43:58.170Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06190158" }, { "nct_id": "NCT01626235", "title": "AMPED Outcomes Registry of Post-ED Pain Management", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Soft Tissue Injuries", "Gouty Arthritis", "Fractures", "Ureteral Colic", "Dysmenorrhea" ], "interventions": [], "intervention_types": [], "sponsor": "Radnor Registry Research, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 843, "start_date": "2012-07", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2014-03-12", "last_synced_at": "2026-10-15T02:43:58.170Z", "location_count": 11, "location_summary": "Birmingham, Alabama • New Orleans, Louisiana • Jackson, Mississippi + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Jackson", "state": "Mississippi" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Tulsa", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT01626235" }, { "nct_id": "NCT05640180", "title": "An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Kidney Disease", "Type 2 Diabetes" ], "interventions": [ { "name": "Finerenone (Kerendia, BAY94-8862)", "type": "DRUG" }, { "name": "Sodium-glucose cotransporter-2 inhibitors (SGLT2i)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17847, "start_date": "2022-11-23", "completion_date": "2023-12-20", "has_results": false, "last_update_posted_date": "2024-01-08", "last_synced_at": "2026-10-15T02:43:58.170Z", "location_count": 1, "location_summary": "Whippany, New Jersey", "locations": [ { "city": "Whippany", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05640180" }, { "nct_id": "NCT03226899", "title": "A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Gout", "Chronic Kidney Disease (CKD)" ], "interventions": [ { "name": "Lesinurad", "type": "DRUG" }, { "name": "XOI", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "colchicine", "type": "DRUG" }, { "name": "corticosteroids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ironwood Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 242, "start_date": "2017-07-19", "completion_date": "2019-02-25", "has_results": true, "last_update_posted_date": "2021-11-04", "last_synced_at": "2026-10-15T02:43:58.170Z", "location_count": 70, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Covina, California + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03226899" }, { "nct_id": "NCT00120926", "title": "Dose Comparison of Amino Acids on Growth in Premature Neonates", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Malnutrition" ], "interventions": [ { "name": "Parenteral Nutrition", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pediatrix", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "48 Hours", "sex": "ALL", "summary": "0 Years to 48 Hours" }, "enrollment_count": 150, "start_date": "2005-08", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2006-09-28", "last_synced_at": "2026-10-15T02:43:58.170Z", "location_count": 1, "location_summary": "Florence, South Carolina", "locations": [ { "city": "Florence", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00120926" }, { "nct_id": "NCT06736743", "title": "Review of Infant Oral Feeding and Skills", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Nutrition Disorders", "Gastrointestinal Disease", "Deglutition Disorder", "Feeding Difficulties", "Swallowing Difficulties", "Humans", "Cohort Studies", "Infant, Newborn", "Infant, Premature, Nutrition", "Pediatric Feeding Disorder, Chronic", "Retrospective Studies", "Breastfeeding", "Mental Health Wellness", "Intensive Care Units, Neonatal", "Bottle Feeding" ], "interventions": [ { "name": "SMART Tool for Feeding Skill Assessment", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Weeks", "maximum_age": "42 Weeks", "sex": "ALL", "summary": "22 Weeks to 42 Weeks" }, "enrollment_count": 108, "start_date": "2025-03-01", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2026-08-03", "last_synced_at": "2026-10-15T02:43:58.170Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06736743" }, { "nct_id": "NCT02547935", "title": "A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus, CKD and Albuminuria" ], "interventions": [ { "name": "Dapagliflozin 10 mg", "type": "DRUG" }, { "name": "Saxagliptin 2.5 mg", "type": "DRUG" }, { "name": "Matching Placebo for Dapagliflozin 10 mg and Saxagliptin 2.5mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 459, "start_date": "2015-09-21", "completion_date": "2018-05-18", "has_results": true, "last_update_posted_date": "2019-08-21", "last_synced_at": "2026-10-15T02:43:58.170Z", "location_count": 37, "location_summary": "Peoria, Arizona • Chula Vista, California • Concord, California + 34 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Concord", "state": "California" }, { "city": "El Centro", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02547935" }, { "nct_id": "NCT04595370", "title": "Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Heart Failure", "Chronic Kidney Disease" ], "interventions": [ { "name": "AZD9977", "type": "DRUG" }, { "name": "Dapagliflozin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "21 Years to 130 Years" }, "enrollment_count": 153, "start_date": "2021-01-26", "completion_date": "2023-09-22", "has_results": true, "last_update_posted_date": "2024-11-19", "last_synced_at": "2026-10-15T02:43:58.170Z", "location_count": 26, "location_summary": "Beverly Hills, California • Fountain Valley, California • Northridge, California + 22 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "South Gate", "state": "California" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04595370" } ] }